×
Pediatrix Medical EBIT 2010-2024 | MD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pediatrix Medical ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
Pediatrix Medical EBIT 2010-2024 | MD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pediatrix Medical ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$133.5B
Elevance Health (ELV)
$96.1B
CVS Health (CVS)
$84.8B
Cencora (COR)
$55.6B
DiDi Global (DIDIY)
$20.3B
Natera (NTRA)
$20B
BioMerieux (BMXMF)
$15.6B
Solventum (SOLV)
$11.5B
ICON (ICLR)
$11.3B
EUROFINS SCIENT (ERFSF)
$11.1B
Revvity (RVTY)
$11B
CochLear (CHEOY)
$10.9B
Avantor (AVTR)
$10.3B
Doximity (DOCS)
$9.9B
Viatris (VTRS)
$9B
Medpace Holdings (MEDP)
$9B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.3B
Charles River Laboratories (CRL)
$5.2B
Amplifon S.p.A (AMFPF)
$4.3B
Bausch + Lomb (BLCO)
$4.3B
Alignment Healthcare (ALHC)
$3.5B
Sotera Health (SHC)
$3B
BrightSpring Health Services (BTSG)
$2.9B
Organon (OGN)
$2.9B
Surgery Partners (SGRY)
$2.7B
GeneDx Holdings (WGS)
$2.7B
Concentras Parent (CON)
$2.6B
Progyny (PGNY)
$1.8B
Ardent Health Partners (ARDT)
$1.8B